Paul Akerman

2.7k total citations
58 papers, 1.8k citations indexed

About

Paul Akerman is a scholar working on Surgery, Gastroenterology and Oncology. According to data from OpenAlex, Paul Akerman has authored 58 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Surgery, 24 papers in Gastroenterology and 23 papers in Oncology. Recurrent topics in Paul Akerman's work include Gastrointestinal Bleeding Diagnosis and Treatment (21 papers), Gastrointestinal disorders and treatments (20 papers) and Lung Cancer Treatments and Mutations (15 papers). Paul Akerman is often cited by papers focused on Gastrointestinal Bleeding Diagnosis and Treatment (21 papers), Gastrointestinal disorders and treatments (20 papers) and Lung Cancer Treatments and Mutations (15 papers). Paul Akerman collaborates with scholars based in United States, Mexico and Argentina. Paul Akerman's co-authors include Daniel Cantero, Howard Safran, Anna Mae Diehl, S. Q. Yang, Christopher B. McClain, G. J. Bagby, Sally Nelson, Deepak Agrawal, David A. Iannitti and T. A. Kennedy and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Hepatology.

In The Last Decade

Paul Akerman

57 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Akerman United States 21 1.0k 685 613 457 284 58 1.8k
Hannah van Malenstein Belgium 18 698 0.7× 369 0.5× 261 0.4× 279 0.6× 211 0.7× 59 1.4k
Yoshihisa Sakaguchi Japan 24 857 0.8× 950 1.4× 590 1.0× 375 0.8× 104 0.4× 104 1.9k
Yasuhiko Nagano Japan 31 1.2k 1.2× 951 1.4× 1.1k 1.8× 237 0.5× 473 1.7× 104 2.5k
Yasuharu Ikeda Japan 21 585 0.6× 385 0.6× 574 0.9× 126 0.3× 351 1.2× 62 1.4k
Genichi Nishimura Japan 20 659 0.6× 550 0.8× 399 0.7× 315 0.7× 129 0.5× 62 1.5k
Takashi Nagaie Japan 10 643 0.6× 1.4k 2.0× 781 1.3× 620 1.4× 108 0.4× 44 1.8k
Yukihito Kokuba Japan 20 548 0.5× 492 0.7× 503 0.8× 141 0.3× 99 0.3× 104 1.2k
Masahiko Tsurumaru Japan 25 2.2k 2.1× 1.9k 2.8× 587 1.0× 215 0.5× 205 0.7× 131 3.0k
Nozomu Machida Japan 20 429 0.4× 802 1.2× 819 1.3× 251 0.5× 255 0.9× 135 1.4k
Wataru Adachi Japan 20 772 0.8× 398 0.6× 526 0.9× 102 0.2× 349 1.2× 93 1.7k

Countries citing papers authored by Paul Akerman

Since Specialization
Citations

This map shows the geographic impact of Paul Akerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Akerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Akerman more than expected).

Fields of papers citing papers by Paul Akerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Akerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Akerman. The network helps show where Paul Akerman may publish in the future.

Co-authorship network of co-authors of Paul Akerman

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Akerman. A scholar is included among the top collaborators of Paul Akerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Akerman. Paul Akerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ward, Christopher, et al.. (2021). S2424 New Diagnosis of Severe Ulcerative Colitis Immediately Following mRNA-1273 SARS-CoV2 Vaccination. The American Journal of Gastroenterology. 116(1). S1027–S1027. 4 indexed citations
2.
Akerman, Paul, et al.. (2019). Successful Endoscopic Reduction of an Ileocolonic Intussusception in an Adult With Peutz-Jeghers Syndrome. Gastroenterology Research. 12(1). 40–42. 5 indexed citations
3.
4.
Akerman, Paul, et al.. (2012). Spiral enteroscopy: Prime time or for the happy few?. Best Practice & Research Clinical Gastroenterology. 26(3). 293–301. 11 indexed citations
5.
Akerman, Paul & Daniel Cantero. (2009). Spiral Enteroscopy and Push Enteroscopy. Gastrointestinal Endoscopy Clinics of North America. 19(3). 357–369. 32 indexed citations
6.
7.
Safran, Howard, Mohan Suntharalingam, Thomas Ng, et al.. (2008). Cetuximab With Concurrent Chemoradiation for Esophagogastric Cancer: Assessment of Toxicity. International Journal of Radiation Oncology*Biology*Physics. 70(2). 391–395. 83 indexed citations
8.
Evans, Devon, et al.. (2007). A Phase I Study of Docetaxel, Oxaliplatin, and Capecitabine in Patients With Metastatic Gastroesophageal Cancer. American Journal of Clinical Oncology. 30(4). 346–349. 17 indexed citations
9.
Evans, Devon, Thomas J. Miner, David A. Iannitti, et al.. (2007). Docetaxel, Capecitabine and Carboplatin in Metastatic Esophagogastric Cancer: A Phase II Study. Cancer Investigation. 25(6). 445–448. 11 indexed citations
10.
Milas, Luka, Devon Evans, Paul Akerman, et al.. (2006). Paclitaxel Poliglumex (PPX-Xyotax) and Concurrent Radiation for Esophageal and Gastric Cancer. American Journal of Clinical Oncology. 29(4). 376–379. 56 indexed citations
11.
Safran, Howard, Thomas A. DiPetrillo, Paul Akerman, et al.. (2006). Phase I/II study of trastuzumab, paclitaxel, cisplatin and radiation for locally advanced, HER2 overexpressing, esophageal adenocarcinoma. International Journal of Radiation Oncology*Biology*Physics. 67(2). 405–409. 88 indexed citations
12.
Tsai, James, David A. Iannitti, Anna Berkenblit, et al.. (2005). Phase I Study of Docetaxel, Capecitabine, and Carboplatin in Metastatic Esophagogastric Cancer. American Journal of Clinical Oncology. 28(4). 329–333. 9 indexed citations
13.
Iannitti, David A., et al.. (2005). Erlotinib and Chemoradiation Followed by Maintenance Erlotinib for Locally Advanced Pancreatic Cancer. American Journal of Clinical Oncology. 28(6). 570–575. 66 indexed citations
14.
Safran, Howard, David A. Iannitti, Daniel Quirk, et al.. (2002). Gemcitabine, paclitaxel, and radiation for locally advanced pancreatic cancer: a phase i trial. International Journal of Radiation Oncology*Biology*Physics. 54(1). 137–141. 50 indexed citations
15.
Safran, Howard, Todd T. Moore, David A. Iannitti, et al.. (2001). Paclitaxel and concurrent radiation for locally advanced pancreatic cancer. International Journal of Radiation Oncology*Biology*Physics. 49(5). 1275–1279. 54 indexed citations
16.
Safran, Howard, Margaret M. Steinhoff, Shamlal Mangray, et al.. (2001). Overexpression of the HER-2/ neu Oncogene in Pancreatic Adenocarcinoma. American Journal of Clinical Oncology. 24(5). 496–499. 134 indexed citations
17.
Safran, Howard, Henning A. Gaissert, Paul Akerman, et al.. (2001). Paclitaxel, Cisplatin, and Concurrent Radiation for Esophageal Cancer. Cancer Investigation. 19(1). 1–7. 50 indexed citations
18.
Safran, Howard, Harry Wanebo, Paul J. Hesketh, et al.. (2000). Paclitaxel and concurrent radiation for gastric cancer. International Journal of Radiation Oncology*Biology*Physics. 46(4). 889–894. 26 indexed citations
19.
Khandelwal, Mukul, et al.. (1995). Endoscopic therapy of a bleeding duodenal diverticulum.. PubMed. 90(8). 1328–9. 18 indexed citations
20.
Akerman, Paul, et al.. (1990). Incidence of arrhythmia with central venous catheter insertion and exchange. Journal of Parenteral and Enteral Nutrition. 14(2). 152–155. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hannah van Malenstein Breakdown of academic impact, for papers by Yoshihisa Sakaguchi Breakdown of academic impact, for papers by Yasuhiko Nagano Breakdown of academic impact, for papers by Yasuharu Ikeda Breakdown of academic impact, for papers by Genichi Nishimura Breakdown of academic impact, for papers by Takashi Nagaie Breakdown of academic impact, for papers by Yukihito Kokuba Breakdown of academic impact, for papers by Masahiko Tsurumaru Breakdown of academic impact, for papers by Nozomu Machida Breakdown of academic impact, for papers by Wataru Adachi
Rankless by CCL
2026